Sorrento Therapeutics
SRNEQ
$0.03000
Share price
3.45%
Change (1 day)
-85.00%
Change (1 year)
Categories
Sorrento Therapeutics (SRNEQ) - P/B ratio
P/B ratio as of May 2024 : -0.0835
According to Sorrento Therapeutics
's latest financial reports the company has a price-to-book ratio of -0.0835.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Sorrento Therapeutics - P/B ratio (from 2007 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -0.3439 | -98.22% |
| 2022-12-31 | -19.3 | -203.05% |
| 2021-12-31 | 18.7 | 40.24% |
| 2020-12-31 | 13.4 | -22.89% |
| 2019-12-31 | 17.3 | 1124.23% |
| 2018-12-31 | 1.41 | -7.01% |
| 2017-12-31 | 1.52 | -53.66% |
| 2016-12-31 | 3.28 | 40.6% |
| 2015-12-31 | 2.33 | -30.36% |
| 2014-12-31 | 3.35 | 20.05% |
| 2013-12-31 | 2.79 | -61.56% |
| 2012-12-31 | 7.26 | -38.8% |
| 2011-12-31 | 11.9 | -59.9% |
| 2010-12-31 | 29.6 | -78.08% |
| 2009-12-31 | 135 | -418.22% |
| 2008-12-31 | -42.4 | -106.63% |
| 2007-12-31 | 640 | |
| 2006-12-31 | N/A | |
| 2005-12-31 | N/A | |
| 2004-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Karyopharm Therapeutics
KPTI | -0.9149 | 995.12% | 🇺🇸 USA |
 Exelixis EXEL | 2.98 | -3,665.25% | 🇺🇸 USA |